JP Drafts (September 2017)

JP drafts for public comments, September 1 - 30, 2017

New general tests

• 6.17  Insoluble Particulate Matter Test for Therapeutic Protein Injections (001-1709eng.pdf)

JP drafts for public comments, September 1 - November 30, 2017

New monographs

• Cefalotin Sodium for Injection (002-1709eng.pdf)
• Dexamethasone Sodium Phosphate (003-1709eng.pdf)
• Diclofenac Sodium Suppositories (004-1709eng.pdf)
• Minocycline Hydrochloride Granules (005-1709eng.pdf)
• Ritodrine Hydrochloride Injection (006-1709eng.pdf)

To send the comment on these drafts, the guidance is as follows:
 

1. Download the form for comments in  Word format
2. Fill in the form
3. Prepare and attach the supportive data that scientifically validate the comment when appropriate
4. Send it to the email address: JPdraft1709eng●pmda.go.jp

Note: For the purpose of security, this email address is partly incorrect. Please replace ● with @
when sending an email.

Related Information

• Columns (Chemical drug)
   

Note: The information provided with the comment may be released to the public whenever necessary (except the individual name, organization, address, telephone & fax numbers and e-mail address or the attached supportive data).